Piper Sandler analyst Jason Bednar has reiterated an 'Overweight' rating on Merit Medical Systems (MMSI) and increased its price target from $96 to $106. This indicates a positive outlook from the analyst, suggesting potential upside for the stock.
Piper Sandler analyst Jason Bednar has maintained an 'Overweight' rating on Merit Medical Systems (MMSI) and raised the price target from $96 to $106. This action signals increased confidence from the analyst in the company's future performance and valuation. The primary affected party is MMSI, as this analyst upgrade could attract more investor attention and potentially drive short-term stock price appreciation. While not a major catalyst like an earnings report, a raised price target from a reputable firm can provide a positive sentiment boost. The key opportunity for traders is to consider the potential for short-term upward movement based on this analyst's revised outlook.